Natera
Natera™ has developed one of the largest known clinicogenomic database for renal disease. This database is built with matched data from 40,000 patients who have received the Renasight™ test, a 385-gene panel for patients with kidney disease. Natera’s™ database enables drug developers to accelerate pre-clinical target discovery, enroll clinical trials faster, and maximize budgets for approved targeted therapies.
